{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:30:29Z","timestamp":1790422229967,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4,15]]},"DOI":"10.1097\/qai.0b013e3180314b46","type":"journal-article","created":{"date-parts":[[2007,1,23]],"date-time":"2007-01-23T09:03:40Z","timestamp":1169543020000},"page":"557-561","source":"Crossref","is-referenced-by-count":44,"title":["Hepatitis B Virus Genotypes and Lamivudine Resistance Mutations in HIV\/Hepatitis B Virus-Coinfected Patients"],"prefix":"10.1097","volume":"44","author":[{"given":"Bel\u00e9n","family":"Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz","family":"Mart\u00edn-Carbonero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Sheldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Labarga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Barreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garc\u00eda-Samaniego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210131","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199712113372406","article-title":"Hepatitis B virus infection.","volume":"337","author":"Lee","year":"1997","journal-title":"N Engl J Med"},{"key":"R2-9-20210131","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1053\/jhep.2002.33161","article-title":"Clinical significance of hepatitis B virus genotypes.","volume":"35","author":"Chu","year":"2002","journal-title":"Hepatology"},{"key":"R3-9-20210131","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2893.1999.00174.x","article-title":"Does hepatitis B virus HBV genotype influence the clinical outcome of HBV infection?","volume":"6","author":"Mayerat","year":"1999","journal-title":"J Viral Hepat"},{"key":"R4-9-20210131","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1053\/gast.2002.37041","article-title":"Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in Western patients.","volume":"123","author":"Sanchez-Tapias","year":"2002","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"R5-9-20210131","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-8278(01)80047-7","article-title":"Molecular characteristics of hepatitis B virus genotype A confer a higher response to interferon treatment.","volume":"34","author":"Hou","year":"2001","journal-title":"J Hepatol"},{"key":"R6-9-20210131","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jmv.2028","article-title":"Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw.","volume":"65","author":"Tsubota","year":"2001","journal-title":"J Med Virol"},{"key":"R7-9-20210131","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/088922203322280874","article-title":"Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: therapeutic implications.","volume":"8","author":"Perez-Olmeda","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R8-9-20210131","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.aids.0000200537.86984.0e","article-title":"Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV.","volume":"20","author":"Lacombe","year":"2006","journal-title":"AIDS"},{"key":"R9-9-20210131","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.aids.0000163936.99401.fe","article-title":"Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort.","volume":"19","author":"Konopnicki","year":"2005","journal-title":"AIDS"},{"key":"R10-9-20210131","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(02)00315-8","article-title":"Global control of hepatitis B virus.","volume":"2","author":"Kao","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"R11-9-20210131","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.aids.0000163948.62176.e7","article-title":"Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV international panel.","volume":"19","author":"Soriano","year":"2005","journal-title":"AIDS"},{"key":"R12-9-20210131","first-page":"27","article-title":"Hepatitis B virus coinfection in HIV-infected subjects.","volume":"4","author":"Puoti","year":"2002","journal-title":"AIDS Rev"},{"key":"R13-9-20210131","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","article-title":"HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter AIDS Cohort Study (MACS).","volume":"360","author":"Thio","year":"2002","journal-title":"Lancet"},{"key":"R14-9-20210131","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1086\/496921","article-title":"Treatment of chronic hepatitis B in HIV-infected persons: thinking outside the black box.","volume":"41","author":"Thio","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R15-9-20210131","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new non-invasive method for assessment of hepatic fibrosis.","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"key":"R16-9-20210131","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1006\/viro.1994.1060","article-title":"Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes.","volume":"198","author":"Norder","year":"1994","journal-title":"Virology"},{"key":"R17-9-20210131","first-page":"67","article-title":"A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness.","volume":"81","author":"Stuyver","year":"2000","journal-title":"J Gen Virol"},{"key":"R18-9-20210131","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1099\/0022-1317-83-8-2059","article-title":"Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America.","volume":"83","author":"Arauz-Ruiz","year":"2002","journal-title":"J Gen Virol"},{"key":"R19-9-20210131","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/516458","article-title":"Genotypes and geographic origin of hepatitis B virus: large-scale analysis using a new genotyping method.","volume":"175","author":"Lindh","year":"1997","journal-title":"J Infect Dis"},{"key":"R20-9-20210131","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/hep.1840220605","article-title":"Hepatitis B virus infection: precore mutants and its relation to viral genotypes and core mutations.","volume":"22","author":"Rodriguez-Frias","year":"1995","journal-title":"Hepatology"},{"key":"R21-9-20210131","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/jhep.2003.50352","article-title":"Prevalence of HBV precore\/core promoter variants in the United States.","volume":"38","author":"Chu","year":"2003","journal-title":"Hepatology"},{"key":"R22-9-20210131","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(00)80279-2","article-title":"Rapid detection of genotypes and mutations in the basal core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity.","volume":"33","author":"Grandjacques","year":"2000","journal-title":"J Hepatol"},{"key":"R23-9-20210131","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1053\/he.2000.6709","article-title":"Clinical relevance of hepatitis B viral mutations.","volume":"31","author":"Hunt","year":"2000","journal-title":"Hepatology"},{"key":"R24-9-20210131","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0168-8278(00)80135-X","article-title":"Hepatitis B genotypes and the response to interferon therapy.","volume":"33","author":"Kao","year":"2000","journal-title":"J Hepatol"},{"key":"R25-9-20210131","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1073\/pnas.88.19.8495","article-title":"Inhibition of the replication of hepatitis B virus in vitro by 2,3dideoxy-3-thiacytidine and related analogues.","volume":"88","author":"Doong","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"R26-9-20210131","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1128\/AAC.36.4.733","article-title":"()-2-deoxy-3-thiacytidine is a potent, highly selective inhibitor of HIV type 1 and type 2 replication in vitro.","volume":"36","author":"Coates","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-9-20210131","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/jhep.2001.22166","article-title":"Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region.","volume":"33","author":"Stuyver","year":"2001","journal-title":"Hepatology"},{"key":"R28-9-20210131","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/01.aids.0000218550.85081.59","article-title":"Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.","volume":"20","author":"Matthews","year":"2006","journal-title":"AIDS"},{"key":"R29-9-20210131","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/00002030-200307250-00009","article-title":"Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals.","volume":"17","author":"Cooley","year":"2003","journal-title":"AIDS"},{"key":"R30-9-20210131","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1053\/jhep.2001.25084","article-title":"Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B antigen seroconversion rates: results after 3 years of therapy.","volume":"33","author":"Leung","year":"2001","journal-title":"Hepatology"},{"key":"R31-9-20210131","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/viro.2001.1246","article-title":"Reduced antigenicity of the HBV HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy.","volume":"293","author":"Torresi","year":"2002","journal-title":"Virology"},{"key":"R32-9-20210131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(05)17701-0","article-title":"Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.","volume":"365","author":"Janssen","year":"2005","journal-title":"Lancet"},{"key":"R33-9-20210131","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1089\/aid.2006.22.842","article-title":"Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy.","volume":"22","author":"Nunez","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R34-9-20210131","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/135965350400900522","article-title":"Management of antiviral resistance in patients with chronic hepatitis B.","volume":"9","author":"Locarnini","year":"2004","journal-title":"Antivir Ther"},{"key":"R35-9-20210131","first-page":"1030","article-title":"Antiviral options for the treatment of chronic hepatitis B.","volume":"57","author":"Osborn","year":"2006","journal-title":"Int J Antimicrob Agents"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-200704150-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T11:19:08Z","timestamp":1707563948000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200704150-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,15]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3180314b46","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4,15]]}}}